The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials.
 
Jessica Tao
No Relationships to Disclose
 
Michael H. Eubank
No Relationships to Disclose
 
Erika Pamer
No Relationships to Disclose
 
Nicholas Anthony Cangemi
No Relationships to Disclose
 
Alexander E. Drilon
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Genentech/Roche; Ignyta; Loxo; Pfizer; Takeda; TP Therapeutics
 
James J. Harding
Consulting or Advisory Role - Bristol-Myers Squibb; CytomX Therapeutics; Lilly
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst); Polaris (Inst)
 
Alison M. Schram
No Relationships to Disclose
 
Lillian Mary Smyth
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Other Relationship - Roche/Genentech
 
Komal L. Jhaveri
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Spectrum Pharmaceuticals
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Guardant Health; Mersana; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); GRAIL (Inst); Illumina (Inst); Roche/Genentech (Inst)
 
Debyani Chakravarty
No Relationships to Disclose
 
Ahmet Zehir
No Relationships to Disclose
 
Michael F. Berger
Research Funding - Illumina
 
Nikolaus Schultz
No Relationships to Disclose
 
Alisa Pinkhasik
Stock and Other Ownership Interests - Enanta (I)
 
Stacy B. Thomas
No Relationships to Disclose
 
Peter D. Stetson
No Relationships to Disclose
 
Stuart M. Gardos
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - ArQule; AstraZeneca; Atara Biotherapeutics; Bayer; Boehringer Ingelheim; Chugai Pharma; CytomX Therapeutics; Debiopharm Group; Genentech; Pfizer
Research Funding - AstraZeneca; Loxo; Puma Biotechnology